Stocks and InvestingStocks and Investing
Wed, April 26, 2023
Tue, April 25, 2023
Mon, April 24, 2023

Andrew Mok Maintained (ACHC) at Strong Buy with Decreased Target to $92 on, Apr 24th, 2023


Published on 2024-10-28 02:59:03 - WOPRAI, Andrew Mok
  Print publication without navigation


Andrew Mok of UBS, Maintained "Acadia Healthcare Company, Inc." (ACHC) at Strong Buy with Decreased Target from $96 to $92 on, Apr 24th, 2023.

Andrew has made no other calls on ACHC in the last 4 months.



There are 3 other peers that have a rating on ACHC. Out of the 3 peers that are also analyzing ACHC, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Ann Hynes of "Mizuho" Maintained at Hold with Decreased Target to $80 on, Monday, March 6th, 2023
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $88 on, Wednesday, March 1st, 2023


This is the rating of the analyst that currently disagrees with Andrew


  • Pito Chickering of "Deutsche Bank" Downgraded from Hold to Strong Sell and Decreased Target to $63 on, Thursday, April 20th, 2023